PHIA Koninklijke Philips N.V.

Philips enables hospitals and GPs to remotely screen and monitor patients with COVID-19

Philips enables hospitals and GPs to remotely screen and monitor patients with COVID-19

April 1, 2020

  • Philips provides healthcare institutions with telehealth solution to process high volume coronavirus-related healthcare requests via online screening, and supports healthcare providers in the use of external call centers to offer the correct care to patients
  • If medically justified, patients infected with COVID-19 can be remotely monitored via automated questionnaires about their home situation and state of health

Amsterdam, the Netherlands (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it can help general practitioners and healthcare institutions manage the increased patient flows resulting from the COVID-19 outbreak through a dedicated and scalable telehealth solution that facilitates the use of online screening, follow-up questionnaires and monitoring, and external call center collaborations. It aims to prevent unnecessary visits to general practitioners and hospitals and the remote monitoring of the vast majority of COVID-19 patients that are in quarantine at home.

As a first step, patients complete an online questionnaire at home. Based on the results, the caregiver can let the online solution assign patients to a risk class and take appropriate actions. If needed patients can be monitored via automated follow-up surveys. Patients with a high-risk score are called by a call center for additional information. If the call center determines that care is required, the patient is referred to the GP, who can then provide the necessary care or send them to the hospital. While the questionnaire is intended to support care providers, it is explicitly not a substitute for regular or emergency care. The solution is based on Philips’ existing and proven Patient Reported Outcomes Management solution, which is being used by more than 100 healthcare institutions globally.

The Groene Hart Hospital in Gouda, the Netherlands, is one of the healthcare institutions that has not only already started using the COVID-19 screening and monitoring solution but has also contributed to its development. “We are using this application to relieve the enormous pressure currently placed on our healthcare system,” said Ronald Liem, Head of Surgery at the Groene Hart Hospital. “Together with general practitioners and the Dutch public health service, we can now focus on the most urgent cases and determine, based on the answers from the surveys, which patients do and which do not need additional care.”

“The outbreak of the new coronavirus is a major challenge for everyone in healthcare,” said Roy Jakobs, Chief Business Leader Connected Care, member of the Executive Committee, Royal Philips. “That is why we have equipped one of our existing and proven telehealth solutions with the capabilities to screen and monitor patients remotely. This remote screening solution supports healthcare institutes to diagnose and treat patients at alternative points of care and is helping to safeguard the scarce critical care capacity.”

Roy Jakobs added: “We have a broad portfolio of telehealth and remote care solutions at Philips. We are now working with hospitals and GPs to see how we can use these solutions to help frontline healthcare workers and their patients during the COVID-19 crisis.”

Hospitals, general practitioners and other care providers who want to know more about Philips’ screening and monitoring solution for COVID-19 patients can .

For further information, please contact:

Joost Maltha

Philips Global Press Office

Tel: 6

Email:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 80,000 employees with sales and services in more than 100 countries. News about Philips can be found at .



 

Attachment

EN
01/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips provides update on the Annual General Meeting of Shareholders ...

Philips provides update on the Annual General Meeting of Shareholders 2025 Agenda April 25, 2025 Amsterdam, the Netherlands –  (NYSE: PHG, AEX: PHIA) provides an update on the Annual General Meeting 2025 which has been convened on March 24, 2025 (AGM). As previously announced, the AGM agenda includes the proposal to appoint Mr Bob White (American, 1962) as a new member of the Supervisory Board, with effect from May 8, 2025, given his extensive expertise and experience in health technology and quality. Since the company published the agenda for the AGM, Mr White has been nominated to be...

 PRESS RELEASE

Philips demonstrates innovation power, topping European Patent Office ...

Philips demonstrates innovation power, topping European Patent Office Medtech filings in 2024 March 25, 2025 Amsterdam, the Netherlands –  (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that in 2024 it was the leading applicant in the field of medical technology at the (EPO), filing 594 Medtech patent applications. This achievement underscores the company's ongoing dedication to transforming healthcare delivery by integrating informatics and AI to improve workflows, enhance the quality of care, and lower costs of care per patient.The innovations by Philips, ...

 PRESS RELEASE

Philips and Ibex expand partnership to enhance AI-enabled pathology wo...

Philips and Ibex expand partnership to enhance AI-enabled pathology workflows for better patient care March 24, 2025 Interoperable AI-powered digital pathology workflows support confident cancer diagnosis Amsterdam, The Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its partnership with Ibex Medical Analytics (Ibex) and a new release of Philips IntelliSite Pathology Solution (PIPS) to further accelerate the adoption of AI-enabled digital pathology to address the pressure pathologists face because of the global shortage of pat...

 PRESS RELEASE

Philips convenes the Annual General Meeting of Shareholders 2025

Philips convenes the Annual General Meeting of Shareholders 2025 March 24, 2025Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA) today announced it has convened the Annual General Meeting of Shareholders (AGM) 2025 and published the agenda with explanatory notes.As previously announced, the agenda includes: Proposal to appoint Mr Bob White (American, 1962) as a new member of the Supervisory Board, with effect from May 8, 2025.Proposals to re-appoint Ms Indra Nooyi (American, 1955) and Ms Chua Sock Koong (Singaporean, 1957) as members of the Supervisory Board, with effect from May 8, 202...

 PRESS RELEASE

Philips highest ranked medical technology company among Clarivate Top ...

Philips highest ranked medical technology company among Clarivate Top 100 Global Innovators March 12, 2025Amsterdam, the Netherlands –  (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has been recognized by Clarivate as the top-ranked medical technology company in the , reinforcing its global reputation as a leading healthcare innovator. A consistent high-performer, Philips has been included in this major assessment of global innovators for 12 consecutive years. Roy Jakobs, CEO of Royal Philips said: "At Philips, we’ve been innovating for over 130 years to i...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch